LENVIMA
Live / Registered — Registered and renewed (as of 26 Jul 2025)
What this means for you
Registered since 26 May 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 May 2025).
Record
- Serial number
- 85778136
- Registration number
- 4744029
- Mark type
- Stylized text
- Filed
- 13 Nov 2012
- Published for opposition
- 16 Apr 2013
- Registered
- 26 May 2015
- Next maintenance due
- 26 May 2025
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of oncological diseases
Owner
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
Prosecution history
- 26 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 26 Jul 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Mar 2025 — TEAS SECTION 8 & 9 RECEIVED
- 26 May 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Sept 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Sept 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 May 2021 — TEAS SECTION 8 & 15 RECEIVED
- 26 May 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 May 2015 — REGISTERED-PRINCIPAL REGISTER
- 21 Apr 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Apr 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Apr 2015 — STATEMENT OF USE PROCESSING COMPLETE